Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[K-ras mutation predictive significance in platinum based chemotherapeutic protocols in patients with advanced non-small cell lung cancer].

Vojnosanitetski pregled - 1 Feb 2009

Cvetković Gordana, Plavec Goran, Tomić Ilija, Ilić Vesna, Magić Zvonko, Tatomirović Zeljka, Novković Dobrivoje, Milić Rade, Karlicić Vukojica

Abstract excerpt

BACKGROUND/AIM: K-ras oncogene is mutated in about 20% of lung cancer. The purpose of this study was to investigate the predictive significance for therapeutic response of K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients. METHODS: Bronchial aspirate samples were assessed prior to platinum-based chemotherapy start in 39 patients with stage IIIb or IV NSCLC. K-ras mutations at codons 12 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Genes, ras

Share to Lung Neoplasms

Share to Mutation

Share to Platinum Compounds

Share to Prognosis

Source

Identifiers

PMID: 19281127
DOI: 10.2298/vsp0902149c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[K-ras mutation predictive significance in platinum based chemotherapeutic protocols in patients with advanced non-small cell lung cancer].PMID 19281127Read ↗

Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?Semantic proximity Read ↗

Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer.Semantic proximity Read ↗

[A simple look at the molecular biology of lung cancer: K-Ras].Semantic proximity Read ↗

K-ras genotypes and prognosis in non-small-cell lung cancer.Semantic proximity Read ↗

Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma.Semantic proximity Read ↗

Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer.Semantic proximity Read ↗

Automated real-time PCR to determine K-ras codon 12 mutations in non-small cell lung cancer: comparison with immunohistochemistry and clinico-pathological features.Semantic proximity Read ↗

Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.Semantic proximity Read ↗

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.Semantic proximity Read ↗

[Successful individualized and targeted therapy of an NSCLC patient with Gefitinib based on a predictive assessment of the EGF-receptor mutation status].Semantic proximity Read ↗

K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungSemantic proximity Read ↗

Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.